Investigation of novel dexrazoxane analogue JR-311 shows significant cardioprotective effects through topoisomerase IIbeta but not its iron chelating metabolite-Reference-Cited by-同舟云学术

Investigation of novel dexrazoxane analogue JR-311 shows significant cardioprotective effects through topoisomerase IIbeta but not its iron chelating metabolite

Published:2017-12 Issue: Volume:392 Page:1-10
ISSN:0300-483X
Container-title:Toxicology
language:en
Short-container-title:Toxicology

Author:

Bures Jan,Jirkovska Anna,Sestak Vit,Jansova Hana,Karabanovich Galina,Roh Jaroslav,Sterba Martin,Simunek Tomas,Kovarikova Petra

Funder

Charles University in Prague

Czech Science Foundation

PROGRES Q40

Publisher

Elsevier BV

Subject

Toxicology

Reference45 articles.

1. Influence of the cardioprotective agent dexrazoxane on doxorubicin pharmacokinetics in the dog;Baldwin;Cancer Chemother. Pharmacol.,1992

2. Bioanalytical Method Validation, Guidance for Industry;CDER,2001

3. A fluorescence assay for assessing chelation of intracellular iron in a membrane model system and in mammalian cells;Cabantchik;Anal. Biochem.,1996

4. Detection of necrosis by release of lactate dehydrogenase activity;Chan;Methods Mol. Biol.,2013

5. Neonatal rat cardiomyocytes–a model for the study of morphological, biochemical and electrophysiological characteristics of the heart;Chlopcikova;Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub.,2001

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity;Frontiers in Pharmacology;2024-06-26

2. Poly (ADP-ribose) polymerase pathway inhibitor (Olaparib) upregulates SERCA2a expression and attenuates doxorubicin-induced cardiomyopathy in mice;Environmental Toxicology and Pharmacology;2023-10

3. Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions;Biomedicine & Pharmacotherapy;2023-10

4. RGS7 balances acetylation/de-acetylation of p65 to control chemotherapy-dependent cardiac inflammation;Cellular and Molecular Life Sciences;2023-08-17

5. Targeting mitochondrial dynamics proteins for the treatment of doxorubicin-induced cardiotoxicity;Frontiers in Molecular Biosciences;2023-08-03